Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$388K Hold
1,755
0.01% 268
2025
Q4
$445K Hold
1,755
0.02% 233
2025
Q3
$434K Sell
1,755
-77
-4% -$18.4K 0.02% 206
2025
Q2
$440K Buy
1,832
+77
+4% +$17.9K 0.02% 206
2025
Q1
$398K Hold
1,755
0.02% 189
2024
Q4
$361K Hold
1,755
0.02% 190
2024
Q3
$426K Hold
1,755
0.03% 178
2024
Q2
$385K Buy
1,755
+11
+0.6% +$2.39K 0.02% 170
2024
Q1
$392K Hold
1,744
0.03% 168
2023
Q4
$383K Hold
1,744
0.03% 156
2023
Q3
$383K Hold
1,744
0.03% 141
2023
Q2
$392K Hold
1,744
0.03% 142
2023
Q1
$334K Buy
1,744
+28
+2% +$5.41K 0.03% 142
2022
Q4
$317K Hold
1,716
0.03% 134
2022
Q3
$285K Sell
1,716
-43
-2% -$8.75K 0.04% 149
2022
Q2
$363K Sell
1,759
-157
-8% -$35.4K 0.06% 130
2022
Q1
$463K Sell
1,916
-47
-2% -$10.9K 0.06% 131
2021
Q4
$478K Hold
1,963
0.04% 133
2021
Q3
$401K Hold
1,963
0.04% 138
2021
Q2
$405K Buy
1,963
+90
+5% +$18.1K 0.04% 139
2021
Q1
$357K Hold
1,873
0.04% 142
2020
Q4
$355K Hold
1,873
0.05% 130
2020
Q3
$330K Hold
1,873
0.05% 125
2020
Q2
$287K Buy
+1,873
New +$285K 0.05% 146

Other funds holding STE

GM Advisory Group's STE Position: Q1 2026 in Review

GM Advisory Group held its Steris (STE) position steady in Q1 2026 at 1,755 shares worth $388K. The position accounts for 0.01% of the portfolio, ranked #268.

GM Advisory Group first reported a position in STE in Q2 2020 and has held it in 24 quarters since. The position peaked at $478K in Q4 2021. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • GM Advisory Group held 1,755 shares of Steris worth $388K as of Q1 2026.
  • GM Advisory Group left its Steris share count unchanged in Q1 2026.
  • Steris made up 0.01% of GM Advisory Group's portfolio in Q1 2026, its #268 holding.
  • GM Advisory Group first reported a position in Steris in Q2 2020 and has held it in 24 quarters since.
  • GM Advisory Group's Steris position peaked at $478K in Q4 2021.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.